Portfolio Holdings Detail for ISIN IE00BMX0DF60

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam

Holdings detail for SIBN

Show aggregate SIBN holdings

News associated with SIBN

SiBone (NASDAQ:SIBN) Stock Rating Lowered by Wall Street Zen

SiBone (NASDAQ:SIBN – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday. A number of other equities research analysts have also recently weighed in on SIBN. Truist Financial lifted their price target on shares of SiBone from […] - 2025-08-11 03:50:57

Insider Selling: SiBone (NASDAQ:SIBN) Insider Sells 3,310 Shares of Stock

SiBone (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 3,310 shares of the firm’s stock in a transaction on Wednesday, July 2nd. The shares were sold at an average price of $18.27, for a total value of $60,473.70. Following the completion of the transaction, the insider owned 279,121 shares in the company, valued […] - 2025-07-09 05:40:56

Anshul Maheshwari Sells 5,005 Shares of SiBone (NASDAQ:SIBN) Stock

SiBone (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 5,005 shares of SiBone stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $18.34, for a total value of $91,791.70. Following the completion of the sale, the chief financial officer directly owned 217,078 shares of the company’s […] - 2025-07-09 05:40:55

Johnson Investment Counsel Inc. Invests $148,000 in SiBone (NASDAQ:SIBN)

Johnson Investment Counsel Inc. purchased a new position in SiBone (NASDAQ:SIBN – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,516 shares of the company’s stock, valued at approximately $148,000. A number of other hedge funds have also made […] - 2025-06-24 05:06:50

Squarepoint Ops LLC Makes New Investment in SI-BONE, Inc. (NASDAQ:SIBN)

Squarepoint Ops LLC bought a new stake in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 32,060 shares of the company’s stock, valued at approximately $449,000. Other institutional investors and hedge funds also recently […] - 2025-06-05 05:16:57

SI-BONE, Inc. (NASDAQ:SIBN) Shares Purchased by Deutsche Bank AG

Deutsche Bank AG grew its holdings in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 53.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,268 shares of the company’s stock after acquiring an additional 12,561 shares during the period. Deutsche Bank […] - 2025-05-30 04:46:49

Man Group plc Purchases New Stake in SI-BONE, Inc. (NASDAQ:SIBN)

Man Group plc acquired a new position in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 15,454 shares of the company’s stock, valued at approximately $217,000. Other hedge funds have also added to or reduced their stakes in the company. Mainstream Capital Management LLC […] - 2025-05-28 05:00:56

Analysts Expect 22% Upside For ESML

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-27 09:59:02

SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Lazard Asset Management LLC

Lazard Asset Management LLC increased its holdings in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 50.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 68,839 shares of the company’s stock after acquiring an additional 23,015 shares during the quarter. Lazard Asset Management LLC […] - 2025-05-21 05:22:50

BNP Paribas Financial Markets Sells 3,886 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

BNP Paribas Financial Markets lowered its position in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,556 shares of the company’s stock after selling 3,886 shares during the quarter. BNP Paribas […] - 2025-05-19 04:36:54

SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 4,937 Shares

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 4,937 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $19.02, for a total value of $93,901.74. Following the completion of the transaction, the chief financial officer now owns 232,069 shares in the […] - 2025-05-15 05:06:53

Price T Rowe Associates Inc. MD Purchases 3,318 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

Price T Rowe Associates Inc. MD grew its position in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 11.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,742 shares of the company’s stock after acquiring an additional 3,318 shares during the […] - 2025-05-14 04:42:48

Voya Investment Management LLC Sells 1,412 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

Voya Investment Management LLC lessened its holdings in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,292 shares of the company’s stock after selling 1,412 shares during the period. Voya Investment Management […] - 2025-05-12 07:18:47

SI-BONE (NASDAQ:SIBN) Shares Gap Up Following Strong Earnings

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) gapped up before the market opened on Tuesday following a better than expected earnings announcement. The stock had previously closed at $14.25, but opened at $15.84. SI-BONE shares last traded at $16.17, with a volume of 305,591 shares traded. The company reported ($0.15) EPS for the quarter, beating […] - 2025-05-08 02:25:02

XTX Topco Ltd Purchases New Position in SI-BONE, Inc. (NASDAQ:SIBN)

XTX Topco Ltd purchased a new stake in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,200 shares of the company’s stock, valued at approximately $171,000. A number of other hedge funds and […] - 2025-04-29 05:01:03

Michael A. Pisetsky Sells 3,128 Shares of SI-BONE, Inc. (NASDAQ:SIBN) Stock

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) SVP Michael A. Pisetsky sold 3,128 shares of the company’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $14.14, for a total transaction of $44,229.92. Following the transaction, the senior vice president now directly owns 244,878 shares of the […] - 2025-04-08 05:14:53

SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $46,850.65 in Stock

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 3,311 shares of the firm’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $14.15, for a total transaction of $46,850.65. Following the transaction, the insider now directly owns 284,555 shares of the […] - 2025-04-08 05:14:53

SI-BONE, Inc. (NASDAQ:SIBN) Receives $24.50 Average Target Price from Brokerages

Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) have earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the […] - 2025-03-06 04:57:24

SI-BONE (NASDAQ:SIBN) Reaches New 1-Year High Following Analyst Upgrade

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) shares reached a new 52-week high on Wednesday after Needham & Company LLC raised their price target on the stock from $20.00 to $24.00. Needham & Company LLC currently has a buy rating on the stock. SI-BONE traded as high as $19.35 and last traded at $17.90, with […] - 2025-02-27 07:52:56

SI-BONE (NASDAQ:SIBN) Shares Gap Up Following Earnings Beat

Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) gapped up prior to trading on Tuesday following a stronger than expected earnings report. The stock had previously closed at $17.47, but opened at $19.11. SI-BONE shares last traded at $17.97, with a volume of 201,031 shares. The company reported ($0.11) EPS for the quarter, topping […] - 2025-02-27 04:53:11

SI-BONE (NASDAQ:SIBN) Given New $24.00 Price Target at Needham & Company LLC

SI-BONE (NASDAQ:SIBN – Free Report) had its target price increased by Needham & Company LLC from $20.00 to $24.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, Truist Financial boosted their price target on shares of SI-BONE from $16.00 to $18.00 and gave […] - 2025-02-26 06:48:58

SI-BONE (NASDAQ:SIBN) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of SI-BONE (NASDAQ:SIBN – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. The firm currently has a $25.00 price target on the stock. A number of other equities research analysts have also weighed in on the stock. Truist Financial lifted their target price […] - 2025-02-26 06:48:56

SI-BONE (NASDAQ:SIBN) Sees Large Volume Increase – Still a Buy?

Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) saw strong trading volume on Tuesday . 657,680 shares were traded during trading, an increase of 113% from the previous session’s volume of 308,078 shares.The stock last traded at $17.46 and had previously closed at $16.39. Wall Street Analysts Forecast Growth Several equities research analysts recently […] - 2025-02-19 04:51:20

iShares US Medical Devices UCITS ETF SIBN holdings

Date	Number of SIBN Shares Held	Base Market Value of SIBN Shares	Local Market Value of SIBN Shares	Change in SIBN Shares Held	Change in SIBN Base Value	Current Price per SIBN Share Held	Previous Price per SIBN Share Held
2025-09-26 (Friday)	5,177	USD 72,737	USD 72,737
2025-09-25 (Thursday)	5,177	USD 73,203	USD 73,203
2025-09-24 (Wednesday)	4,849	USD 68,953	USD 68,953
2025-09-18 (Thursday)	4,849	USD 73,608	USD 73,608	0	USD 2,279	USD 15.18	USD 14.71
2025-09-17 (Wednesday)	4,849	USD 71,329	USD 71,329	0	USD -1,891	USD 14.71	USD 15.1
2025-09-16 (Tuesday)	4,849	USD 73,220	USD 73,220
2025-09-15 (Monday)	4,849	USD 73,414	USD 73,414
2025-09-12 (Friday)	4,849	USD 76,129	USD 76,129
2025-09-11 (Thursday)	4,849	USD 79,136	USD 79,136

Share Trades of SIBN by Blackrock for IE00BMX0DF60

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-06-27	SELL	-84			18.430*		15.73 Profit of 1,321 on sale
2025-06-12	BUY	123			18.260*		15.60
2025-06-10	SELL	-640			19.100*		15.55 Profit of 9,954 on sale
2025-06-09	SELL	-760			18.860*		15.53 Profit of 11,801 on sale
2025-05-30	SELL	-80			18.900*		15.36 Profit of 1,229 on sale
2025-05-19	BUY	40			19.450*		15.09
2025-05-09	SELL	-225			18.490*		14.88 Profit of 3,348 on sale
2025-04-23	SELL	-47			13.820*		14.87 Profit of 699 on sale
2025-04-17	SELL	-46			13.850*		14.93 Profit of 687 on sale
2025-04-10	BUY	360			13.250*		15.02
2025-04-04	SELL	-90			13.470*		15.09 Profit of 1,358 on sale
2025-04-02	SELL	-90			14.360*		15.10 Profit of 1,359 on sale
2025-03-31	SELL	-135			14.030*		15.13 Profit of 2,043 on sale
2025-03-19	SELL	-41			15.300*		15.19 Profit of 623 on sale
2025-02-28	SELL	-80			18.120*		15.05 Profit of 1,204 on sale
2025-02-05	BUY	135			18.100*		14.14
2025-02-04	BUY	180			17.920*		14.05
2025-01-29	SELL	-45			17.220*		13.74 Profit of 618 on sale
2025-01-23	SELL	-45			16.520*		13.43 Profit of 604 on sale
2025-01-02	SELL	-78			13.930*		13.42 Profit of 1,047 on sale
2024-12-04	BUY	114			13.790*		13.37
2024-12-03	SELL	-41			13.020*		13.38 Profit of 549 on sale
2024-12-02	SELL	-492			13.370*		13.38 Profit of 6,583 on sale
2024-11-29	SELL	-840			13.560*		13.37 Profit of 11,232 on sale
2024-11-27	SELL	-126			13.270*		13.38 Profit of 1,686 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SIBN

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer